Sabra Health Care Reit, Inc. SBRA
We take great care to ensure that the data presented and summarized in this overview for Sabra Health Care REIT, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SBRA
View all-
Vanguard Group Inc Valley Forge, PA34.4MShares$664 Million0.01% of portfolio
-
Black Rock Inc. New York, NY34.4MShares$663 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA21.4MShares$413 Million0.21% of portfolio
-
State Street Corp Boston, MA11.8MShares$228 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA6.19MShares$119 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X05.05MShares$97.3 Million0.04% of portfolio
-
Bank Of America Corp Charlotte, NC4.75MShares$91.6 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL4.38MShares$84.4 Million0.15% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.34MShares$83.6 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.39MShares$65.4 Million0.01% of portfolio
Latest Institutional Activity in SBRA
Top Purchases
Top Sells
About SBRA
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (?Senior Housing - Leased?), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing - Managed?), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Insider Transactions at SBRA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 17
2024
|
Michael J Foster Director |
SELL
Bona fide gift
|
Direct |
1,350
-1.79%
|
-
|
Aug 30
2024
|
Jessica Flores Executive VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
348
+0.58%
|
-
|
Aug 30
2024
|
Ann Kono Director |
BUY
Grant, award, or other acquisition
|
Direct |
793
+1.7%
|
-
|
Aug 30
2024
|
Jeffrey A. Malehorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
889
+0.94%
|
-
|
Aug 30
2024
|
Clifton J Porter Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
803
+1.68%
|
-
|
Aug 30
2024
|
Catherine Cusack Director |
BUY
Grant, award, or other acquisition
|
Direct |
783
+1.35%
|
-
|
Aug 30
2024
|
Lynne S Katzmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
889
+1.38%
|
-
|
Aug 30
2024
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
889
+1.63%
|
-
|
Aug 30
2024
|
Richard K Matros Chair, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
12,159
+1.7%
|
-
|
Aug 30
2024
|
Michael J Foster Director |
BUY
Grant, award, or other acquisition
|
Direct |
889
+1.17%
|
-
|
Aug 30
2024
|
Michael Lourenco Costa Executive VP, CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,624
+1.03%
|
-
|
Aug 30
2024
|
Talya Nevo Hacohen Executive VP, CIO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,985
+1.7%
|
-
|
Jun 13
2024
|
Michael J Foster Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+11.3%
|
-
|
Jun 13
2024
|
Lynne S Katzmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+13.11%
|
-
|
Jun 13
2024
|
Ann Kono Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+17.36%
|
-
|
Jun 13
2024
|
Jeffrey A. Malehorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+9.24%
|
-
|
Jun 13
2024
|
Clifton J Porter Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+16.99%
|
-
|
Jun 13
2024
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+13.06%
|
-
|
Jun 13
2024
|
Catherine Cusack Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,480
+14.35%
|
-
|
May 31
2024
|
Lynne S Katzmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,076
+1.98%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 612K shares |
---|---|
Open market or private purchase | 7K shares |
Bona fide gift | 93K shares |
Payment of exercise price or tax liability | 89.2K shares |
---|---|
Bona fide gift | 94.4K shares |
Open market or private sale | 10K shares |